Catching Up to U.S., Europe
China Clarifies Phase IV Study Rules with Proposed Guidelines
By Cornelia Zou
Wednesday, November 6, 2013
HONG KONG – Authorities in China are working to plug a regulatory hole related to post-market studies for new chemical entities (NCE) and biological drugs.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.